#CD4

The country is urged to offer treatment to everyone who has HIV regardless of CD4 count; most cases are among young men.

Treating HIV early, before CD4s drop significantly, lowers the risk of infection-related cancers.

Researchers have found that in addition to CD4s, macrophage cells can harbor HIV even in the face of antiretroviral treatment.

Researchers have used the cutting-edge CRISPR/Cas9 gene-editing technology to identify five potential targets for HIV treatments.

U.S. Justice Department takes up the case and sues the NYPD over HIV discrimination.

In a post titled “Fighting My Way Up,” POZ blogger Aundaray Guess reflects on his struggles with adherence to his HIV medications.

Immunotherapy and an HIV vaccine are among the first round of grants from Fred Hutch’s Evergreen Fund.

How to decide when to start antiretroviral therapy and which drugs to take

My recent good news reminded me how I used to struggle with adhering to my medication

At least in the short term, reducing CD4 tests among those with stable HIV from every three months to every six to 12 months appears safe.

Scientists have created a two-headed protein that awakens latently HIV-infected immune cells and summons an immune response to kill them.

Aundaray Guess reflects on the meaning of his AIDS diagnosis in an excerpt of a recent POZ blog post.

Two of three in one cohort of Sangamo Biosciences’ investigational gene therapy have maintained control of the virus for an extended period.